HIV/STI update: Where do we go from here?
Presented by: Randolph Hubach, PhD, MPH
Session 1 Objectives:
- Assess current HIV/STI trends in the United States
- Evaluate disparities within current trends
- Identify opportunities for research and intervention to address HIV/STI disparities
Hepatitis C [HCV] Elimination-Improved Screening and Linkage to Care Approaches
Presented by: Imtiaz Alam, MD
Session 2 Objectives:
- HCV elimination goals and reducing disease burden
- HCV screening and testing recommendations
- Linkage to care and expanding the HCV care continuum
Addressing Substance Use Disorders, HCV and Neuropsychiatric Impairments from a Psychoneuroimmunology Research Perspective
Presented by: Jennifer Loftis, Ph.D.
Session 3 Objectives:
- Identify key inflammatory factors that contribute to psychiatric symptoms and cognitive impairments, particularly in the context of SUD and co-morbid viral infection
- Describe current and emerging theories of SUD (alcohol and methamphetamine) and HCV effects on brain and neuropsychiatric function
- Integrate the role of inflammatory mechanisms in the treatment of SUD, HCV and related neuropsychiatric impairments
Dangerous Liaisons: The Intersection Between the SUD, HCV and HIV Epidemic in Indian Country
Presented by: Jorge Mera, MD, FACP
Session 4 Objectives:
- Participants will understand and explain the concept of a Syndemic
- Participants will recognize the interaction of the SUD epidemic in relation to the HCV and HIV epidemics in Indian Country
- Participants will be able to describe interventions to mitigate the SUD, HCV and HIV Syndemic at a Macro (societal), Micro (health system) and individual (health professional) level
HIV and Transgender Health
Presented by: Aliza Norwood, MD, AAHIVS
Session 5 Objectives:
- Describe the epidemiology of HIV in the transgender community
- Review factors that impact the HIV care continuum specific to transgender individuals
- Discuss the impact of gender-affirming care on HIV prevention and treatment